Wall Street analyst estimates for Reinsurance Group of America, Incorporated (RGA): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Reinsurance Group of America, Inc. (RGA) primarily operates within the reinsurance sector. The company delivers a comprehensive portfolio of life and health reinsurance products, spanning both individual and group coverages. These include diverse life insurance options such as term, credit, universal, whole, and joint/last survivor policies, in addition to critical illness, disability, and longevity products.
Consensus price target
$273.67 (+4 % vs price $263.45)
between $236.00 and $295.00 · 6 targets published in the last quarter
Closing price, Oct 29
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $27.0B | $26.7B – $27.3B | $29.86 | 6 |
| 2027E | $28.1B | $27.2B – $28.9B | $30.07 | 6 |
Figures in USD · consensus as of October 29, 2026
Analyst Consensus
| Strong Buy | 0 |
| Buy | 13 |
| Hold | 8 |
| Sell | 2 |
| Strong Sell | 0 |
| Total analysts | 23 |
| Avg rating (−2 sell to +2 buy) | 0.48 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-05 | $6.97 | ||
| 2026-08-06 | $8.89 | $6.50 | +36.8% |
| 2026-05-07 | $6.97 | $6.03 | +15.6% |
| 2026-02-05 | $7.75 | $5.78 | +34.1% |
| 2025-10-30 | $6.37 | $5.76 | +10.6% |
| 2025-07-31 | $4.72 | $5.58 | -15.4% |
| 2025-05-01 | $5.66 | $5.31 | +6.6% |
| 2025-02-06 | $4.99 | $5.24 | -4.8% |
Valuation Ratios
| P/E Ratio | 11.58 |
| Price / Book | 1.27 |
| EV / EBITDA | 7.68 |
| Dividend Yield | 1.43% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.52B | $12.52B | $12.88B | $14.20B | $14.58B | $16.06B | $15.88B | $18.39B | $22.04B | $22.79B |
| Cost of Revenue | $9.67B | $10.49B | $11.07B | $12.10B | $13.04B | $14.21B | $14.31B | $16.06B | $19.55B | $17.00B |
| Gross Profit | $1.85B | $2.03B | $1.81B | $2.10B | $1.54B | $1.85B | $1.57B | $2.33B | $2.49B | $5.79B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | $809.0M | $885.0M | $963.0M | $969.0M | $991.0M | $469.0M | $853.0M | $1.17B | $1.51B | $4.25B |
| Operating Income | $1.04B | $1.14B | $846.0M | $1.13B | $553.0M | $1.39B | $718.0M | $1.16B | $980.0M | $1.54B |
| EBITDA | $1.21B | $1.34B | $1.04B | $1.35B | $772.0M | $1.57B | $947.0M | $1.46B | $1.33B | $1.95B |
| Interest Expense | $137.6M | $146.0M | $147.0M | $173.0M | $170.0M | $139.0M | $191.0M | $257.0M | $304.0M | $366.0M |
| Pre-tax Income | $1.04B | $1.14B | $846.0M | $1.13B | $553.0M | $1.39B | $718.0M | $1.16B | $980.0M | $1.54B |
| Income Tax | $342.5M | -$679.0M | $130.0M | $262.0M | $138.0M | $215.0M | $197.0M | $251.0M | $256.0M | $351.0M |
| Net Income | $701.4M | $1.82B | $716.0M | $870.0M | $415.0M | $1.17B | $517.0M | $902.0M | $717.0M | $1.18B |
| EPS | $10.91 | $28.28 | $11.25 | $13.88 | $6.35 | $9.10 | $7.73 | $13.60 | $10.90 | $17.94 |
| EPS (Diluted) | $10.79 | $27.71 | $11.00 | $13.62 | $6.31 | $9.04 | $7.64 | $13.44 | $10.73 | $17.69 |
| Shares Outstanding (Diluted) | 65.0 M | 65.8 M | 65.1 M | 63.9 M | 65.8 M | 68.3 M | 67.7 M | 67.1 M | 66.9 M | 66.7 M |
Price
| Price | $263.45 (closing price, October 29, 2026) |
| Market Cap | $17.2B |
| Exchange | NYSE |
| Country | US |
Related companies: EG · RNR · HG · SPNT
Explore sector: Financial Services · Insurance - Reinsurance
More sections of RGA: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks